Latest Breaking News On - Managing science editor - Page 9 : comparemela.com

Safety of Oral DMTs for RRMS in Real-world Use Match Trial Findings

Safety of Oral DMTs for RRMS in Real-world Use Match Trial Findings
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

United statesScott carsonRick millerUniversity of lisbonDuquesne university school of pharmacyBiomedical sciencesAcademy of managed care pharmacySociety of americaUniversity of pittsburghAlliancerx walgreens primeDuquesne university schoolManaged care pharmacyDays coveredAlliancerx walgreensMolecular pathologyMolecular biology

Repertoire, Yale Collaborate to Identify T-cells Driving MS

Repertoire Immune Medicines and Yale University collaborate on research to identify antigens that activate immune T-cells in people with multiple sclerosis.

Anthony coyleDavid haflerYale universityYale school of medicineUniversity of lisbonBiomedical sciencesRepertoire immune medicinesYale schoolYale new havenMolecular biologyUniversidade nova de lisboaManaging science editorஅந்தோணி கோய்ல்யேல் பல்கலைக்கழகம்யேல் பள்ளி ஆஃப் மருந்துபல்கலைக்கழகம் ஆஃப் லிஸ்பன்

Restless Legs Syndrome Linked to Greater Disability, Spinal Lesions in MS

A study in MS patients found the syndrome more common in those with more advanced disease, and affecting both sleep and daytime sleepiness.

Ms clinic of the department neurologyUniversity of lisbonBiomedical sciencesUniversity of viennaLegs syndromeMultiple sclerosisMedical universityExpanded disability status scalePittsburgh sleep quality indexEpworth sleepiness scaleUniversidade nova de lisboaMolecular biologyManaging science editorபல்கலைக்கழகம் ஆஃப் லிஸ்பன்உயிர் மருத்துவ அறிவியல்பல்கலைக்கழகம் ஆஃப் வியன்னா

Combining Generic, MS Tools Gives Clearer View of Patient Life Quality, Study Says

HRQoL is essentially a measure of the impact that a disease has on patients’ quality of life. While there are a number of instruments that assess HRQoL, disease-specific measures are better tailored to patients with a condition, whereas more generic ones enable comparisons with the general population and people with other diseases. However, the inconsistent use of generic and disease-specific HRQoL tools limits the ability to compare results from MS observational studies and clinical trials. Researchers at Erasmus University Rotterdam, in The Netherlands, set out to use generic and disease-specific tools to assess the HRQoL of adult MS patients in Europe.

Zuid hollandFaisha abdullahUniversity of lisbonArchives of public healthResearchers at erasmus university rotterdamWeill cornell medical collegeBiomedical sciencesUniversity of houstonErasmus university rotterdamMultiple sclerosis qualityMolecular biologyUniversidade nova de lisboaManaging science editorஆயிஷா அப்துல்லாபல்கலைக்கழகம் ஆஃப் லிஸ்பன்காப்பகங்கள் ஆஃப் பொது ஆரோக்கியம்

FDA Rejects Under-the-skin Tysabri for Relapsing MS

FDA Rejects Under-the-skin Tysabri for Relapsing MS
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

United statesLong beachMaha radhakrishnanUniversity of lisbonVirtual american academy of neurology annual meetingEuropean commissionDrug administrationBiomedical sciencesColumbia universityAmerican academyNeurology annualMolecular biologyUniversidade nova de lisboaManaging science editorஒன்றுபட்டது மாநிலங்களில்நீண்டது கடற்கரை